亨通股份：公司围绕主营业务开展了投资与布局

Core Viewpoint - Hengtong Co., Ltd. (600226) is actively engaged in the research, production, and sales of its main business areas, which include electrolytic copper foil, veterinary pharmaceuticals, feed additives, and cogeneration [1] Business Overview - The company has made investments and strategic arrangements around its main business, indicating a proactive approach to growth and diversification [1] - Hengtong and its wholly-owned subsidiaries have invested in and hold stakes in several companies, including Qingdao Yibang Bioengineering Co., Ltd. (17.45% stake), Hebei Shengxue Dacheng Pharmaceutical Co., Ltd. (49% stake), and Zhejiang Ikobike Animal Health Products Co., Ltd. (49% stake) [1]